Skip to content

Ricardo Jorge Dinis-Oliveira

13 papers in the library · 146 citations · publishing 2018-2026

Papers

Sort Most recent Most cited

O impacto da psilocibina versus extrato de Psilocybe cubensis na microbiota intestinal de ratos Wistar Han

Proceedings of Research and Practice in Allied and Environmental Health May 16, 2026 Diana Silva, Francisco Sacadura, Cláudia Marques et al.

Enquadramento: A psilocibina, composto psicoativo principal de cogumelos Psilocybe, tem suscitado interesse pelo potencial terapêutico em perturbações neuropsiquiátricas [1]. Para além dos efeitos centrais, a evidência sobre o eixo intestino-cérebro sugere que os psicadélicos podem influenciar a microbiota intestinal. Extratos integrais contêm compostos bioativos adicionais, mas os dados...

Psilocibina versus extrato de Psilocybe cubensis: efeitos comportamentais e toxicológicos em ratos

Proceedings of Research and Practice in Allied and Environmental Health May 16, 2026 Diana Silva, Andreia Machado Brito-Da-Costa, Francisco Sacadura et al.

Enquadramento: A psilocibina, composto psicoativo de cogumelos Psilocybe, tem sido estudada pelo potencial terapêutico em perturbações neuropsiquiátricas [1]. Contudo, continuam escassos os dados pré-clínicos que comparem psilocibina isolada e extratos integrais, sobretudo quanto ao reforço comportamental e toxicidade periférica [2,3]. Objetivo: Comparar os efeitos comportamentais e...

Pure psilocybin reduces reward-associated preference while mushroom extract shows transient exploratory effects in rats

RevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia May 1, 2026 Andreia Machado Brito-Da-Costa, Francisco Sacadura, Ricardo Jorge Dinis-Oliveira et al.

Introduction: Psilocybin, the main psychoactive compound in Psilocybe mushrooms, has attracted interest for its potential therapeutic effects in neuropsychiatric disorders (Erkizia-Santamaría et al., 2025). However, preclinical data comparing its behavioral properties to whole mushroom extracts remain limited (Ali et al., 2023; Johnson-Groh, 2025). Objective: To investigate the reinforcing and...

Cytochrome P450 Inhibition by Psilocybin and Psilocin: A Combined Molecular Dynamics and Enzymatic Screening Study

RevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia May 1, 2026 Andreia Machado Brito-Da-Costa, Mariana Carvalho, Ricardo Jorge Dinis-Oliveira et al.

Psilocybin is a hallucinogen produced by “magic mushrooms”, being rapidly metabolized in the organism into psilocin (Brito-da-Costa et al., 2022; Dinis-Oliveira, 2017). A scientific gap exists regarding the possible interactions between psilocybin/psilocin and CYP450 enzymes. Given their biological importance and since the binding of drugs to CYP450 enzymes can interfere with the metabolism of...

Investigating Psychedelic Tryptamines: Extraction and Quantification from Psilocybe Mushrooms

Science Letters April 17, 2026 Beatriz P. Senra, Ricardo Jorge Dinis-Oliveira, Carlos J. A. Ribeiro

Background: Psilocybe cubensis mushrooms contain the tryptamines psilocybin and psilocin, which are recognized for their therapeutic potential in mental health [1]. Additionally, due to their psychedelic effects, these mushrooms are also used for religious and recreational purposes. The increasing use of these tryptamines and other psychoactive substances has led to regulatory measures,...

DOI: 10.48797/sl.2026.498 (opens in new tab) Psilocybin Mushroom Extraction chemistry Maceration sewage +6

Psilocybin and Psilocybe cubensis extract exhibit divergent behavioural and toxicological effects in rats

Science Letters April 17, 2026 Diana Dias Da Silva, Andreia Machado Brito-Da-Costa, Francisco Sacadura et al.

Background: Psilocybin, a key psychoactive compound found in Psilocybe mushrooms, has gained increasing attention due to its therapeutic potential in neuropsychiatric disorders [1]. However, comparative preclinical data between isolated psilocybin and whole mushroom extracts remain scarce, particularly regarding behavioural reinforcement and peripheral toxicity [2,3]. Objective: To compare the...

DOI: 10.48797/sl.2026.497 (opens in new tab) Psilocybin Lipid peroxidation Analysis of variance Peripheral +3

Impact of psilocybin and Psilocybe cubensis extract on gut microbiota in Wistar Han rats

Science Letters April 17, 2026 Francisco Sacadura, Cláudia Marques, Andreia Machado Brito-Da-Costa et al.

Background: Psilocybin, the main psychoactive compound found in Psilocybe mushrooms, has gained increasing attention due to its potential therapeutic effects in neuropsychiatric disorders [1]. Beyond its central effects, increasing evidence highlights the relevance of the gut–brain axis, suggesting that psychedelics may also influence intestinal microbiota composition. Whole mushroom extracts...

DOI: 10.48797/sl.2026.492 (opens in new tab) Psilocybin Gut flora Amplicon sequencing Mushroom +5

Psychoactives in 2025: Consolidating an Interdisciplinary Platform for Psychoactive Substance Science and Looking to the Future

Psychoactives April 1, 2026 Ricardo Jorge Dinis-Oliveira

In 2025, Psychoactives continued its clear upward trajectory, strengthening its position as an international, peer-reviewed, open-access journal dedicated to advancing the science of psychoactive substances, spanning pharmacology, clinical psychiatry, toxicology, neuroscience, forensic science, and public health [...]

DOI: 10.3390/psychoactives5020008 (opens in new tab) Psychoactive substance Public health Position finance Psychoactive drug +4

Psilocin as a Broad Inhibitor of CYP450 Enzymes: Integrated In Vitro and In Silico Evidence

Instituto Politécnico do Porto February 25, 2026 Diana Silva, Andreia Machado Brito-Da-Costa, Mariana Carvalho et al.

Background: Psilocybin is a psychoactive compound found in hallucinogenic mushrooms and is rapidly dephosphorylated in vivo to psilocin, its pharmacologically active metabolite. Despite the growing clinical and scientific interest in these substances, information regarding their interaction with cytochrome P450 (CYP450) enzymes remains scarce, raising concerns about potential drug–drug...

Neurotoxic and Neuroprotective Effects of Psychedelics in a Human Neuroblastoma Cell Model

RevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia 2025 Andreia Machado Brito-Da-Costa, Ricardo Jorge Dinis-Oliveira, Áurea Madureira-Carvalho et al.

Psychedelic compounds, including psilocybin, psilocin, lysergic acid diethylamide (LSD), 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT), and mescaline, have long been recognized for their recreational effects and involvement in forensic cases. They have recently gained attention also for their potential therapeutic applications in treating neurological and psychiatric disorders [1]. Despite this...

Pharmacokinetics and Pharmacodynamics of Salvinorin A and Salvia divinorum: Clinical and Forensic Aspects

Pharmaceuticals February 3, 2021 Andreia Machado Brito-Da-Costa, Áurea Madureira-Carvalho, Diana Dias Da Silva et al. 42 citations

Salvia divinorum Epling and Játiva is a perennial mint from the Lamiaceae family, endemic to Mexico, predominantly from the state of Oaxaca. Due to its psychoactive properties, S. divinorum had been used for centuries by Mazatecans for divinatory, religious, and medicinal purposes. In recent years, its use for recreational purposes, especially among adolescents and young adults, has...

DOI: 10.3390/ph14020116 (opens in new tab) Hallucinogen Pharmacology Traditional medicine Drug

Pharmacokinetic and Pharmacodynamic Aspects of Peyote and Mescaline: Clinical and Forensic Repercussions

Current Molecular Pharmacology October 15, 2018 Ricardo Jorge Dinis-Oliveira, Carolina Lança Pereira, Diana Dias Da Silva 101 citations

Background:Mescaline (3,4,5-trimethoxyphenethylamine), mainly found in the Peyote cactus (Lophophora williamsii), is one of the oldest known hallucinogenic agents that influence human and animal behavior, but its psychoactive mechanisms remain poorly understood.Objective:This article aims to fully review pharmacokinetics and pharmacodynamics of mescaline, focusing on the in vivo and in vitro...